GNE-7915
|
GNE7915
|
1351761-44-8
|
PI-3065
|
PI-3065
|
955977-50-1
|
Entasobulin
|
501921-61-5
|
501921-61-5
|
FITM
|
4-氟-N-[4-[6-(異丙基氨基)嘧啶-4-基]-1,3-噻唑-2-基]-N-甲基苯甲酰胺
|
932737-65-0
|
DDD107498
|
DDD107498
|
1469439-69-7
|
JAK3-IN-6
|
JAK3-IN-6
|
1443235-95-7
|
GSK 2643943A
|
GSK2643943A
|
2449301-27-1
|
1H-Indole-3-aceticacid, a-oxo-1-(phenylmethyl)-5-[4-(trifluoromethoxy)phenyl]-
|
替普沙汀
|
393105-53-8
|
GRA Ex-25
|
N-[4-[[[反式-4-(1,1-二甲基乙基)環(huán)己基][[[4-(三氟甲氧基)苯基]氨基]羰基]氨基]甲基]芐基]-B-丙氨酸
|
307983-31-9
|
Indibulin
|
2-(1-(4-氯芐基)-1H-吲哚-3-基)-2-氧代-N-(吡啶-4-基)乙酰胺
|
204205-90-3
|
SEA0400
|
2-[4-[(2,5-二氟苯基)甲氧基]苯氧基]-5-乙氧基苯胺
|
223104-29-8
|
ISX9
|
ISX 9
|
832115-62-5
|
KHS-101
|
KHS101
|
1262770-73-9
|
NVP-LCQ195
|
4-(2,6-二氯苯甲?;被?-1H-吡唑-3-羧酸 N-[1-(甲基磺?;?哌啶-4-基]酰胺
|
902156-99-4
|
STF31
|
4-((4-(叔丁基)苯基磺酰胺基)甲基)-N-(吡啶-3-基)苯甲酰胺
|
724741-75-7
|
CCT241736
|
CS-2683
|
1402709-93-6
|
TG4-155
|
TG4-155
|
1164462-05-8
|
N-[(thiophen-2-yl)methyl]-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine
|
化合物NIH12848
|
959551-10-1
|
PF-9366
|
PF-9366
|
72882-78-1
|
MRT67307
|
N-[3-[[5-環(huán)丙基-2-[[3-(4-嗎啉基甲基)苯基]氨基]-4-嘧啶基]氨基]丙基]環(huán)丁烷甲酰胺
|
1190378-57-4
|
Sobetirome
|
SOBETIROME
|
211110-63-3
|
JW55
|
JW-55
|
664993-53-7
|
AR7
|
CS-2649
|
80306-38-3
|
SR-9243
|
N-[2-(3-溴苯基)乙基]-2,4,6-三甲基-N-[[3'-(甲基磺?;?[1,1'-聯(lián)苯]-4-基]甲基]苯磺酰胺
|
1613028-81-1
|
BMS-1
|
PD-1
|
1675201-83-8
|
GENZ-682452
|
GENZ-682452
|
1401090-53-6
|
gsk2200150a
|
1443138-53-1
|
1443138-53-1
|
LKB1(AAK1dualinhibitor)
|
N-[5-(4-氰基苯基)-1H-吡咯并[2,3-B]吡啶-3-基]-3-吡啶甲酰胺
|
1093222-27-5
|
H -9-91-01
|
N-(2,4-二甲氧基苯基)-N'-(2,6-二甲基苯基)-N-[6-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]脲
|
1456858-58-4
|
GLPG0634 analog
|
GLPG0634
|
1206101-20-3
|
TP0463518
|
TP0463518
|
1558021-37-6
|
BI-4464
|
BI 4464)
|
1227948-02-8
|
UNC2541
|
UNC2541
|
1612782-86-1
|
GSK 114
|
|
|
Nucleozin
|
4-(2-氯-4-硝基苯基)-1-哌嗪基](5-甲基-3-苯基-4-異噁唑基)-甲酮
|
341001-38-5
|
Aurora Kinase Inhibitor III
|
AURORA KINASE INHIBITOR III
|
879127-16-9
|
HG-10-102-01
|
4-[[5-氯-4-(甲基氨基)-2-嘧啶基]氨基]-3-甲氧基苯基]-4-嗎啉基甲酮
|
1351758-81-0
|
Uprosertib
|
UPROSERTIB
|
1047634-65-0
|
IKKε-IN-1
|
CS-1801
|
1292310-49-6
|
GSK2981278
|
GSK2981278
|
1474110-21-8
|
JNJ 63533054
|
3-氯-N-[2-氧代-2-[[(1S)-1-苯基乙基]氨基]乙基]苯甲酰胺
|
1802326-66-4
|
HIF-1 inhibitor-1
|
|
|
Desciclovir
|
地昔洛韋
|
84408-37-7
|
OSI-930
|
3-[(4-喹啉甲基)氨基]-N-[4-(三氟甲氧基)苯基]-2-噻吩甲酰胺
|
728033-96-3
|
PF-8380
|
4-[3-氧代-3-(2-氧代-2,3-二氫苯并惡唑-6-基)丙基]哌嗪-1-羧酸 3,5-二氯芐酯
|
1144035-53-9
|
NVP-BGT226
|
NVP-BGT226
|
1245537-68-1
|
GDC0575 hydrochloride
|
GDC0575 HYDROCHLORIDE
|
1196504-54-7
|
PF-6260933
|
化合物PF6260933
|
1811510-56-1
|
BI-1347
|
BI-1347
|
2163056-91-3
|
ZT-12-037-01
|
ZT-12-037-01
|
2328073-61-4
|
E7820
|
CS-2701
|
289483-69-8
|
LY-293111
|
Etalocib
|
161172-51-6
|
3i-1000
|
化合物GATA4-NKX2-5-IN-1
|
544681-96-1
|
HA130
|
HA 130,自分泌運動抑制劑
|
1229652-21-4
|
INCB8761
|
N-[2-[(3S)-3-[[4-羥基-4-[5-(嘧啶-2-基)吡啶-2-基]環(huán)己基]氨基]吡咯烷-1-基]-2-氧代乙基]-3-(三氟甲基)苯甲酰胺
|
857679-55-1
|
NVP-BSK805
|
NVP-BSK805 dihydrochloride
|
1092499-93-8
|
ASP3026
|
ASP3026
|
1097917-15-1
|
OT-R antagonist 1
|
化合物 T12331L
|
364071-17-0
|
GNF 5837
|
GNF 5837
|
1033769-28-6
|
ML355
|
ML355
|
1532593-30-8
|
T-26c
|
T-26c
|
869296-13-9
|
Bipenquinate
|
布喹那鈉鹽
|
96201-88-6
|
TAK-779
|
TAK 799 ;TAK 779
|
229005-80-5
|
PS48
|
(Z)-5-(4-氯苯基)-3-苯基戊-2-烯酸
|
1180676-32-7
|
XL765
|
XL765
|
1349796-36-6
|
GSK503
|
化合物GSK503
|
1346572-63-1
|
5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo[D] oxazole
|
依珠曲米
|
945531-77-1
|
SGC2085
|
SGC2085
|
1821908-48-8
|
MTX-211
|
MTX-211
|
1952236-05-3
|
ABX-1431
|
ABX-1431
|
1446817-84-0
|
BI 01383298
|
BI 01383298
|
2227549-00-8
|
P110δ-IN-1 ,ME401
|
ME401
|
1595129-71-7
|
SR18662
|
SR18662
|
|
IRAK-1-4 Inhibitor I
|
IRAK-1-4 抑制劑 I
|
509093-47-4
|
TG101209
|
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺
|
936091-14-4
|
IRAK inhibitor
|
環(huán)巴胺抑制劑 1
|
1042224-63-4
|
AX 20017
|
AX 20017
|
329221-38-7
|
ML281
|
ML281
|
1404437-62-2
|
HG-14-10-04
|
CS-1175
|
1356962-34-9
|
PF74
|
PF-3450074
|
1352879-65-2
|
PFI-2 HCl
|
1627607-87-7
|
1627607-87-7
|
EAI045
|
EAI-045
|
1942114-09-1
|
SNS-062
|
SNS062
|
1270014-40-8
|
Methanesulfonamide, N-[4-[[1-[2-(6-methyl-2-pyridinyl)ethyl]-4-piperidinyl]carbonyl]phenyl]-, hydrochloride (1:2)
|
N-[4-[[1-[2-(6-甲基-2-吡啶基)乙基]-4-哌啶基]羰基]苯基]甲烷磺酰胺二鹽酸鹽
|
113559-13-0
|
MRT68921 dihydrochloride
|
化合物MRT68921 DIHYDROCHLORIDE
|
2080306-21-2
|
FDL169
|
FDL169
|
1628416-28-3
|
TTAPE
|
|
|
SNAP 94847 (hydrochloride)
|
SNAP 94847鹽酸鹽
|
1781934-47-1
|
Pleconaril
|
普可那利
|
153168-05-9
|
RAF265
|
RAF265
|
927880-90-8
|
Tirasemtiv
|
TIRASEMTIV(CK-2017357)
|
1005491-05-3
|
Quinoxaline, 2-chloro-3-(4-methyl-1-piperazinyl)-
|
VUF 10166
|
155584-74-0
|
IKK16
|
IKK-16
|
873225-46-8
|
WZ4003
|
WZ4003
|
1214265-58-3
|
LY2828360
|
CS-2878
|
1231220-79-3
|
BAW2881 (NVP-BAW2881)
|
BAW2881
|
861875-60-7
|
MCHr1 antagonist 2
|
863115-70-2
|
863115-70-2
|
JNJ0966
|
JNJ0966
|
315705-75-0
|
LY-2940094
|
BTRX-246040
|
1307245-86-8
|
F-1
|
F-1
|
2244775-31-1
|